Suppr超能文献

巨大肝血管瘤原位肝移植:一例报告

Orthotopic liver transplantation for giant liver haemangioma: A case report.

作者信息

Lange Undine G, Bucher Julian N, Schoenberg Markus B, Benzing Christian, Schmelzle Moritz, Gradistanac Tanja, Strocka Steffen, Hau Hans-Michael, Bartels Michael

机构信息

Undine G Lange, Christian Benzing, Hans-Michael Hau, Michael Bartels, Department of Visceral, Transplant, Thoracic and Vascular Surgery, Leipzig University Hospital, 04103 Leipzig, Germany.

出版信息

World J Transplant. 2015 Dec 24;5(4):354-9. doi: 10.5500/wjt.v5.i4.354.

Abstract

In liver haemangiomas, the risk of complication rises with increasing size, and treatment can be obligatory. Here we present a case of a 46-year-old female who suffered from a giant haemangioma causing severe portal hypertension and vena cava compression, leading to therapy refractory ascites, hyponatremia and venostasis-associated thrombosis with pulmonary embolism. The patients did not experience tumour rupture or consumptive coagulopathy. Surgical resection was impossible because of steatosis of the non-affected liver. Orthotopic liver transplantation was identified as the only treatment option. The patient's renal function remained stable even though progressive morbidity and organ allocation were improbable according to the patient's lab model for end-stage liver disease (labMELD) score. Therefore, non-standard exception status was approved by the European organ allocation network "Eurotransplant". The patient underwent successful orthotopic liver transplantation 16 mo after admission to our centre. Our case report indicates the underrepresentation of morbidity associated with refractory ascites in the labMELD-based transplant allocation system, and it indicates the necessity of promptly applying for non-standard exception status to enable transplantation in patients with a severe clinical condition but low labMELD score. Our case highlights the fact that liver transplantation should be considered early in patients with non-resectable, symptomatic benign liver tumours.

摘要

在肝脏血管瘤中,并发症的风险随肿瘤大小的增加而上升,因此可能需要进行治疗。在此,我们报告一例46岁女性患者,她患有巨大血管瘤,导致严重的门静脉高压和腔静脉受压,进而引发治疗难治性腹水、低钠血症以及与静脉淤滞相关的血栓形成并伴有肺栓塞。患者未出现肿瘤破裂或消耗性凝血病。由于未受影响的肝脏存在脂肪变性,无法进行手术切除。原位肝移植被确定为唯一的治疗选择。尽管根据患者的终末期肝病实验室模型(labMELD)评分,患者的病情可能会逐渐恶化且不太可能获得器官分配,但患者的肾功能仍保持稳定。因此,欧洲器官分配网络“Eurotransplant”批准了非标准例外状态。患者在入住我们中心16个月后成功接受了原位肝移植。我们的病例报告表明,在基于labMELD的移植分配系统中,与难治性腹水相关的发病率未得到充分体现,这表明对于临床状况严重但labMELD评分较低的患者,有必要及时申请非标准例外状态以实现移植。我们的病例突出了一个事实,即对于不可切除的、有症状的良性肝脏肿瘤患者,应尽早考虑肝移植。

相似文献

1
Orthotopic liver transplantation for giant liver haemangioma: A case report.
World J Transplant. 2015 Dec 24;5(4):354-9. doi: 10.5500/wjt.v5.i4.354.
5
Extended liver resection including hypertrophy concept with portal venous embolisation for giant haemangioma. Too much surgery?
Ann Hepatobiliary Pancreat Surg. 2020 Aug 31;24(3):357-361. doi: 10.14701/ahbps.2020.24.3.357.
6
[Personal experience in embolization of liver hemangiomas].
Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):349-54.
7
LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experience.
Clin Transplant. 2011 Sep-Oct;25(5):E558-65. doi: 10.1111/j.1399-0012.2011.01483.x. Epub 2011 May 17.
8
Constrictive pericarditis as a cause of refractory ascites after liver transplantation: A case report.
World J Clin Cases. 2019 Oct 26;7(20):3266-3270. doi: 10.12998/wjcc.v7.i20.3266.
9
Liver transplantation with cavoportal hemitransposition in the presence of diffuse portal vein thrombosis.
Transplantation. 1998 Mar 15;65(5):619-24. doi: 10.1097/00007890-199803150-00004.
10
Extensive Inferior Vena Cava Thrombosis in a Liver Transplant Patient: A Case Report.
Transplant Proc. 2019 Jun;51(5):1629-1632. doi: 10.1016/j.transproceed.2019.05.008.

引用本文的文献

1
An uncommon cause of a giant abdominal mass.
Gastroenterol Hepatol Bed Bench. 2023;16(1):539-541. doi: 10.22037/ghfbb.v16i1.2649.
2
Liver transplantation for giant hemangioma of the liver: A case report and review of the literature.
Front Med (Lausanne). 2022 Sep 15;9:985181. doi: 10.3389/fmed.2022.985181. eCollection 2022.
4
Liver transplantation for benign liver tumors.
World J Hepatol. 2021 Sep 27;13(9):1098-1106. doi: 10.4254/wjh.v13.i9.1098.
5
Benign Liver Tumors.
Visc Med. 2020 Aug;36(4):292-303. doi: 10.1159/000509145. Epub 2020 Aug 4.
7
Living-donor liver transplantation for giant hepatic hemangioma with diffuse hemangiomatosis in an adult: a case report.
Clin Mol Hepatol. 2018 Jun;24(2):163-168. doi: 10.3350/cmh.2017.0002. Epub 2017 Jul 19.

本文引用的文献

2
Cadaveric liver transplantation for a giant mass.
Gastroenterology. 2014 Jan;146(1):e10-1. doi: 10.1053/j.gastro.2013.08.001. Epub 2013 Nov 21.
3
Diagnosis and management of benign liver tumors.
Semin Liver Dis. 2013 Aug;33(3):236-47. doi: 10.1055/s-0033-1351779. Epub 2013 Aug 13.
4
Minimally invasive treatment of giant haemangiomas of the liver: embolisation with bleomycin.
Cardiovasc Intervent Radiol. 2014 Feb;37(1):101-7. doi: 10.1007/s00270-013-0618-y. Epub 2013 Apr 12.
5
Management of giant liver hemangiomas: an update.
Expert Rev Gastroenterol Hepatol. 2013 Mar;7(3):263-8. doi: 10.1586/egh.13.10.
6
Surgical management of giant hepatic hemangiomas: complications and review of the literature.
Chang Gung Med J. 2012 Jan-Feb;35(1):70-8. doi: 10.4103/2319-4170.106164.
7
Region 11 MELD Na exception prospective study.
Ann Hepatol. 2012 Jan-Feb;11(1):62-7.
8
Liver transplantation for giant hepatic angiomyolipoma.
Liver Transpl. 2011 Aug;17(8):985-6. doi: 10.1002/lt.22310.
10
Spontaneous rupture of hepatic hemangiomas: A review of the literature.
World J Hepatol. 2010 Dec 27;2(12):428-33. doi: 10.4254/wjh.v2.i12.428.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验